Cornercap Investment Counsel Inc Foghorn Therapeutics Inc. Transaction History

Cornercap Investment Counsel Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$4.8 - $9.99 $59,616 - $124,075	-12,420 Reduced 48.58%	13,147 $122,000
Q2 2024 Aug 08, 2024	SELL	$5.05 - $8.0 $1,272 - $2,016	-252 Reduced 0.98%	25,567 $147,000
Q3 2023 Nov 13, 2023	SELL	$5.0 - $9.87 $1,720 - $3,395	-344 Reduced 1.31%	25,819 $129,000
Q4 2022 Feb 13, 2023	BUY	$5.44 - $9.46 $142,326 - $247,501	26,163 New	26,163 $166,000

35.7M

8.7K

2.4K

Ticker FHTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,637,400
Market Cap $255M
Description
Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

Stay updated on Cornercap Investment Counsel Inc with notifications on news.